| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |